Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period


  • Published On : Jan-2016 |
  • Pages : 263 Pages |
  • Format :

Opioids are naturally occurring opiates and synthetic and semi-synthetic drugs that act on opioid receptors in the brain and can cause dependence due to their euphoric effects. Opioids are majorly categorized into natural and synthetic opioids that are used to treat moderate to severe pain caused due to various physical conditions.

Increasing usage of opioids in non-cancer conditions, unregulated prescription by physicians, lack of regulatory policies to curb the abusive consumption, increasing the prevalence of terminal conditions and favorable reimbursement for palliative care in developed countries are some of the factors promoting the growth of the global opioids market. However, chronic side effects, high prices of opioids in developing countries, over the regulated opioid prescription environment in Asia Pacific and limited availability in Asia Pacific, Africa and some parts of Europe are expected to hinder the growth of the opioids market, globally.

This report covers the global opioids market performance in terms of revenue contribution. The report includes key trends, drivers, restraints, and opportunities influencing the growth of the global opioids market. Impact analysis of key growth drivers and restraints, based on the weighted average model are included in this report to better equip clients with crystal clear decision-making insights.

The global opioids market is segmented as follows:

  • Opioid market, by Product Type
  • Opioid market, by Application
  • Opioid market, by Region

The global opioids market has been estimated to be valued at US$ 34,888.0 Mn in 2015 and is anticipate to garner US$ 42,158.8 Mn revenue by 2021, registering a CAGR of 3.2% during the forecast period.

By product, the global opioid market is segmented into morphine, codeine, fentanyl, meperidine and methadone. The morphine and codeine segments collectively accounted for around 62% of the overall market in 2014.

By application, the global opioids market is segmented into analgesia, cough suppression and diarrhea suppression. The analgesia segment was valued at US$ 22,776.3 Mn in 2014 and is anticipated to reach US$ 28,436.8 Mn by 2021 at a CAGR of 3.3% over the forecast period.

By geography, North America dominated the market with over 65% market share in 2014, followed by Europe. Opioids market in Asia-Pacific is projected to expand at the highest CAGR of 6.7% during the forecast period.

Key features of this report

  • Drivers and restraints of the opioids market
  • Latest product innovations and key developments in the market
  • Analysis of business strategies of the top players
  • Opioids market estimates and forecasts

An opioid is a type of narcotic pain medication that is used to treat moderate to severe pain. It is used as an anesthesia, cough suppressant, diarrhea suppressant and to reduce surgical pain, injury or trauma, cancer pain and pain arising from disease. Opioids are largely used in cancer pain management and end-stage diseases in which palliative care is required. However, these can be addictive due to their analgesic nature.

The global opioids market was valued at US$ 33,924.2 Mn in 2014. North America was the leading market for opioid, accounting for approximately 65% revenue share in 2014, followed by Europe with around 20% share in 2014. Factors such as increasing palliative care facilities, reformed regulations for prescription of opioids, and extensive focus of generic manufacturers towards Abuse-Deterrent Formulation (ADF) are expected to drive the growth of the opioids market in North America and Europe. Asia Pacific market is expected to register highest CAGR of 3.5% during the forecast period (2015–2021), followed by the North America. Increased focus on palliative care and rising healthcare expenditure are leading factors which promote the growth of opioids in Asia Pacific.

The global opioids market has been estimated to be valued at US$ 34,888.0 Mn in 2015 and is anticipate to garner US$ 42,158.8 Mn revenue by 2021, registering a CAGR of 3.2% during the forecast period.

By product, the morphine and codeine segments collectively accounted for around 62% of the overall market in 2014. Uncontrolled prescription, development of opioid tolerance towards morphine and codeine would raise the demand through 2021.

By application, analgesia segment was valued at US$ 22,776.3 Mn in 2014 and is anticipated to reach US$ 28,436.8 Mn by 2021 at a CAGR of 3.3% over the forecast period.

Key players in the global opioids market include Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc. and Egalet.

opioids-market

Key players in the global opioids market:

  • Pfizer Inc.
  • Purdue Pharma.
  • Boehringer Ingelheim.
  • Janssen Pharmaceuticals, Inc.
  • Actavis Plc.
  • Sanofi.
  • Sun Pharmaceutical Industries Ltd.
  • Mallinckrodt Pharmaceuticals.
  • Endo Pharmaceuticals Inc.
  • Egalet.
  • Other.

These companies are looking for maximum market share with the help of product launch in Abuse Deterrent Formulations (ADF).  Also, major players are focusing on Asia Pacific region especially in Australia owing to flexible regulation for opium cultivation.

Table of Contents

1. Research Methodology

2. Assumption & Acronyms Used

3. Executive Summary

4. Opioids Market Overview
4.1. Parent Market Overview
4.2. Market Taxonomy & Market Definition
4.3. Global Opioid Market Size and Forecast
     4.3.1. Introduction
            4.3.1.1. Global Opioid Market Value & Y-o-Y Growth Rate 2015-2021
            4.3.1.2. Global Opioid Market Absolute $ Opportunity, 2015–2021
4.4. Market Dynamics
     4.4.1. Drivers
     4.4.2. Restraints
     4.4.3. Trends
     4.4.4. Opportunities
     4.4.5. Market Dynamics Impact Analysis

5. Regulations & PEST Analysis
5.1. PEST Analysis
     5.1.1. U.S.
     5.1.2. Canada
     5.1.3. Germany
5.2. Key Regulations
     5.2.1. North America
     5.2.2. Europe
     5.2.3. Asia Pacific
     5.2.4. Middle East & Africa

6. Global Opioid Market Analysis and Forecast By Product Type
6.1. Introduction
     6.1.1. BPS Analysis, By Product Type
     6.1.2. Y-o-Y Growth Comparison, By Product Type
6.2. Morphine
     6.2.1. Market Value & Y-o-Y Growth Rate
     6.2.2. Market Absolute $ Opportunity
6.3. Codeine
     6.3.1. Market Value & Y-o-Y Growth Rate
     6.3.2. Market Absolute $ Opportunity
6.4. Fentanyl
     6.4.1. Market Value & Y-o-Y Growth Rate
     6.4.2. Market Absolute $ Opportunity
6.5. Meperidine
     6.5.1. Market Value & Y-o-Y Growth Rate
     6.5.2. Market Absolute $ Opportunity
6.6. Methadone
     6.6.1. Market Value & Y-o-Y Growth Rate
     6.6.2. Market Absolute $ Opportunity
6.7. Global Opioid Market Attractiveness Analysis By Product Type, 2015–2021

7. Global Opioid Market Analysis and Forecast By Application
7.1. Introduction
     7.1.1. BPS Analysis, By Application
     7.1.2. Y-o-Y Growth Comparison, By Application
7.2. Analgesia
     7.2.1. Market Value & Y-o-Y Growth Rate
     7.2.2. Market Absolute $ Opportunity
7.3. Cough Suppression
     7.3.1. Market Value & Y-o-Y Growth Rate
     7.3.2. Market Absolute $ Opportunity
7.4. Diarrhea Suppression
     7.4.1. Market Value & Y-o-Y Growth Rate
     7.4.2. Market Absolute $ Opportunity
7.5. Global Opioid Market Attractiveness Analysis By Application

8. Global Opioid Market Analysis and Forecast By Region
8.1. Introduction
     8.1.1. BPS Analysis, By Region
     8.1.2. Y-o-Y Growth Comparison, By Region
8.2. North America Opioid Market Analysis and Forecast
     8.2.1. Market Value & Y-o-Y Growth Rate
     8.2.2. Market Absolute $ Opportunity
8.3. Latin America Opioid Market Analysis and Forecast
     8.3.1. Market Value & Y-o-Y Growth Rate
     8.3.2. Market Absolute $ Opportunity
8.4. Europe Opioid Market Analysis and Forecast
     8.4.1. Market Value & Y-o-Y Growth Rate
     8.4.2. Market Absolute $ Opportunity
8.5. Asia Pacific Opioid Market Analysis and Forecast
     8.5.1. Market Value & Y-o-Y Growth Rate
     8.5.2. Market Absolute $ Opportunity
8.6. MEA Opioid Market Analysis and Forecast
     8.6.1. Market Value & Y-o-Y Growth Rate
     8.6.2. Market Absolute $ Opportunity
8.7. Global Opioid Market Attractiveness Analysis By Region

9. North America Opioid Market Analysis
9.1. North America Opioid Market: Trends
9.2. Market Value & Y-o-Y Growth Rate, By Country
9.3. North America Opioid Market: Country Analysis (Absolute $ Opportunity)
     9.3.1. United States Opioid Market: Absolute $ Opportunity
     9.3.2. Canada Opioid Market: Absolute $ Opportunity
9.4. North America Opioid Product Market
     9.4.1. Morphine
            9.4.1.1. Market Value & Y-o-Y Growth Rate
            9.4.1.2. Market Absolute $ Opportunity
     9.4.2. Codeine
            9.4.2.1. Market Value & Y-o-Y Growth Rate
            9.4.2.2. Market Absolute $ Opportunity
     9.4.3. Fentanyl
            9.4.3.1. Market Value & Y-o-Y Growth Rate
            9.4.3.2. Market Absolute $ Opportunity
     9.4.4. Meperidine
            9.4.4.1. Market Value & Y-o-Y Growth Rate
            9.4.4.2. Market Absolute $ Opportunity
     9.4.5. Methadone
            9.4.5.1. Market Value & Y-o-Y Growth Rate
            9.4.5.2. Market Absolute $ Opportunity
9.5. North America Opioid Application Market
     9.5.1. Analgesia
            9.5.1.1. Market Value & Y-o-Y Growth Rate
            9.5.1.2. Market Absolute $ Opportunity
     9.5.2. Cough Suppression
            9.5.2.1. Market Value & Y-o-Y Growth Rate
            9.5.2.2. Market Absolute $ Opportunity
     9.5.3. Diarrhea Suppression
            9.5.3.1. Market Value & Y-o-Y Growth Rate
            9.5.3.2. Market Absolute $ Opportunity
9.6. North America Opioid Market Attractiveness Analysis By Country
9.7. North America Opioid Market Attractiveness Analysis By Product Type
9.8. North America Opioid Market Attractiveness Analysis By Application

10. Latin America Opioid Market Analysis
10.1. Latin America Opioid Market: Trends
10.2. Market Value & Y-o-Y Growth Rate, By Country
10.3. Latin America Opioid Market: Country Analysis (Absolute $ Opportunity)
     10.3.1. Brazil Opioid Market: Absolute $ Opportunity
     10.3.2. Argentina Opioid Market: Absolute $ Opportunity
     10.3.3. Mexico Opioid Market: Absolute $ Opportunity
     10.3.4. Rest of Latin America Opioid Market: Absolute $ Opportunity
10.4. Latin America Opioid Product Market
     10.4.1. Morphine
            10.4.1.1. Market Value & Y-o-Y Growth Rate
            10.4.1.2. Market Absolute $ Opportunity
     10.4.2. Codeine
            10.4.2.1. Market Value & Y-o-Y Growth Rate
            10.4.2.2. Market Absolute $ Opportunity
     10.4.3. Fentanyl
            10.4.3.1. Market Value & Y-o-Y Growth Rate
            10.4.3.2. Market Absolute $ Opportunity
     10.4.4. Meperidine
            10.4.4.1. Market Value & Y-o-Y Growth Rate
            10.4.4.2. Market Absolute $ Opportunity
     10.4.5. Methadone
            10.4.5.1. Market Value & Y-o-Y Growth Rate
            10.4.5.2. Market Absolute $ Opportunity
10.5. Latin America Opioid Application Market
     10.5.1. Analgesia
            10.5.1.1. Market Value & Y-o-Y Growth Rate
            10.5.1.2. Market Absolute $ Opportunity
     10.5.2. Cough Suppression
            10.5.2.1. Market Value & Y-o-Y Growth Rate
            10.5.2.2. Market Absolute $ Opportunity
     10.5.3. Diarrhea Suppression
            10.5.3.1. Market Value & Y-o-Y Growth Rate
            10.5.3.2. Market Absolute $ Opportunity
10.6. Latin America Opioid Market Attractiveness Analysis By Country
10.7. Latin America Opioid Market Attractiveness Analysis By Product Type
10.8. Latin America Opioid Market Attractiveness Analysis By Application

11. Europe Opioid Market Analysis
11.1. Europe Opioid Market: Trends
11.2. Market Value & Y-o-Y Growth Rate, By Country
11.3. Europe Opioid Market: Country Analysis (Absolute $ Opportunity)
     11.3.1. Germany Opioid Market: Absolute $ Opportunity
     11.3.2. U.K. Opioid Market: Absolute $ Opportunity
     11.3.3. Italy Opioid Market: Absolute $ Opportunity
     11.3.4. France Opioid Market: Absolute $ Opportunity
     11.3.5. Spain Opioid Market: Absolute $ Opportunity
     11.3.6. Russia Opioid Market: Absolute $ Opportunity
     11.3.7. Rest of Europe Opioid Market: Absolute $ Opportunity
11.4. Europe Opioid Product Market
     11.4.1. Morphine
            11.4.1.1. Market Value & Y-o-Y Growth Rate
            11.4.1.2. Market Absolute $ Opportunity
     11.4.2. Codeine
            11.4.2.1. Market Value & Y-o-Y Growth Rate
            11.4.2.2. Market Absolute $ Opportunity
     11.4.3. Fentanyl
            11.4.3.1. Market Value & Y-o-Y Growth Rate
            11.4.3.2. Market Absolute $ Opportunity
     11.4.4. Meperidine
            11.4.4.1. Market Value & Y-o-Y Growth Rate
            11.4.4.2. Market Absolute $ Opportunity
     11.4.5. Methadone
            11.4.5.1. Market Value & Y-o-Y Growth Rate
            11.4.5.2. Market Absolute $ Opportunity
11.5. Europe Opioid Application Market
     11.5.1. Analgesia
            11.5.1.1. Market Value & Y-o-Y Growth Rate
            11.5.1.2. Market Absolute $ Opportunity
     11.5.2. Cough Suppression
            11.5.2.1. Market Value & Y-o-Y Growth Rate
            11.5.2.2. Market Absolute $ Opportunity
     11.5.3. Diarrhea Suppression
            11.5.3.1. Market Value & Y-o-Y Growth Rate
            11.5.3.2. Market Absolute $ Opportunity
11.6. Europe Opioid Market Attractiveness Analysis By Country
11.7. Europe Opioid Market Attractiveness Analysis By Product Type
11.8. Europe Opioid Market Attractiveness Analysis By Application

12. Asia Pacific Opioid Market Analysis
12.1. Asia Pacific Opioid Market: Trends
12.2. Market Value & Y-o-Y Growth Rate, By Country
12.3. Asia Pacific Opioid Market: Country Analysis (Absolute $ Opportunity)
     12.3.1. Greater China Opioid Market: Absolute $ Opportunity
     12.3.2. India Opioid Market: Absolute $ Opportunity
     12.3.3. ASEAN Opioid Market: Absolute $ Opportunity
     12.3.4. Australia and New Zealand Opioid Market: Absolute $ Opportunity
     12.3.5. Rest of APAC Opioid Market: Absolute $ Opportunity
12.4. Asia Pacific Opioid Product Market
     12.4.1. Morphine
            12.4.1.1. Market Value & Y-o-Y Growth Rate
            12.4.1.2. Market Absolute $ Opportunity
     12.4.2. Codeine
            12.4.2.1. Market Value & Y-o-Y Growth Rate
            12.4.2.2. Market Absolute $ Opportunity
     12.4.3. Fentanyl
            12.4.3.1. Market Value & Y-o-Y Growth Rate
            12.4.3.2. Market Absolute $ Opportunity
     12.4.4. Meperidine
            12.4.4.1. Market Value & Y-o-Y Growth Rate
            12.4.4.2. Market Absolute $ Opportunity
     12.4.5. Methadone
            12.4.5.1. Market Value & Y-o-Y Growth Rate
            12.4.5.2. Market Absolute $ Opportunity
12.5. Asia Pacific Opioid Application Market
     12.5.1. Analgesia
            12.5.1.1. Market Value & Y-o-Y Growth Rate
            12.5.1.2. Market Absolute $ Opportunity
     12.5.2. Cough Suppression
            12.5.2.1. Market Value & Y-o-Y Growth Rate
            12.5.2.2. Market Absolute $ Opportunity
     12.5.3. Diarrhea Suppression
            12.5.3.1. Market Value & Y-o-Y Growth Rate
            12.5.3.2. Market Absolute $ Opportunity
12.6. Asia Pacific Opioid Market Attractiveness Analysis By Country
12.7. Asia Pacific Opioid Market Attractiveness Analysis By Product Type
12.8. Asia Pacific Opioid Market Attractiveness Analysis By Application

13. MEA Opioid Market Analysis
13.1. MEA Opioid Market: Trends
13.2. Market Value & Y-o-Y Growth Rate, By Country
13.3. MEA Opioid Market: Country Analysis (Absolute $ Opportunity)
     13.3.1. GCC Opioid Market: Absolute $ Opportunity
     13.3.2. South Africa Opioid Market: Absolute $ Opportunity
     13.3.3. Rest of MEA Opioid Market: Absolute $ Opportunity
13.4. MEA Opioid Product Market
     13.4.1. Morphine
            13.4.1.1. Market Value & Y-o-Y Growth Rate
            13.4.1.2. Market Absolute $ Opportunity
     13.4.2. Codeine
            13.4.2.1. Market Value & Y-o-Y Growth Rate
            13.4.2.2. Market Absolute $ Opportunity
     13.4.3. Fentanyl
            13.4.3.1. Market Value & Y-o-Y Growth Rate
            13.4.3.2. Market Absolute $ Opportunity
     13.4.4. Meperidine
            13.4.4.1. Market Value & Y-o-Y Growth Rate
            13.4.4.2. Market Absolute $ Opportunity
     13.4.5. Methadone
            13.4.5.1. Market Value & Y-o-Y Growth Rate
            13.4.5.2. Market Absolute $ Opportunity
13.5. MEA Opioid Application Market
     13.5.1. Analgesia
            13.5.1.1. Market Value & Y-o-Y Growth Rate
            13.5.1.2. Market Absolute $ Opportunity
     13.5.2. Cough Suppression
            13.5.2.1. Market Value & Y-o-Y Growth Rate
            13.5.2.2. Market Absolute $ Opportunity
     13.5.3. Diarrhea Suppression
            13.5.3.1. Market Value & Y-o-Y Growth Rate
            13.5.3.2. Market Absolute $ Opportunity
13.6. MEA Opioid Market Attractiveness Analysis By Country
13.7. MEA Opioid Market Attractiveness Analysis By Product Type
13.8. MEA Opioid Market Attractiveness Analysis By Application

14. Company Profiles
14.1. Company Dashboard
14.2. List of Suppliers and Distributors
14.3. Pfizer
14.4. Purdue Pharma
14.5. Boehringer Ingelheim
14.6. Janssen Pharmaceuticals, Inc.
14.7. Actavis Plc.
14.8. Sanofi
14.9. Sun Pharmaceutical Industries Ltd
14.10. Mallinckrodt Pharmaceuticals
14.11. Endo Pharmaceuticals Inc.
14.12. Egalet


List of Table

Table 01: Global Opioid Market, by Product, 2015–2021 (US$ Mn)
Table 02: Global Opioid Market, by Application, 2014–2021 (US$ Mn)
Table 03: North America Opioids Market, by Country, 2015–2021 (US$ Mn)
Table 04: North America Opioids Market, by Product Type, 2015–2021 (US$ Mn)
Table 05: North America Opioids Market, by Application, 2015–2021 (US$ Mn)
Table 06: Latin America Opioids Market, by Country, 2015–2021 (US$ Mn)
Table 07: Latin America Opioids Market, by Product Type, 2015–2021 (US$ Mn)
Table 08: Latin America Opioids Market, by Application, 2015–2021 (US$ Mn)
Table 09: Europe Opioids Market, by Country, 2015–2021 (US$ Mn)
Table 10: Europe Opioids Market, by Product Type, 2015–2021 (US$ Mn)
Table 11: Europe Opioids Market, by Application, 2015–2021 (US$ Mn)
Table 12: Asia Pacific Opioids Market, by Country, 2015–2021 (US$ Mn)
Table 13: Asia Pacific Opioids Market, by Product Type, 2015–2021 (US$ Mn)
Table 14: Asia Pacific Opioids Market, by Application, 2015–2021 (US$ Mn)
Table 15: MEA Opioids Market, by Country, 2015–2021 (US$ Mn)
Table 16: MEA Opioids Market, by Product Type, 2015–2021 (US$ Mn)
Table 17: MEA Opioids Market, by Application, 2015–2021 (US$ Mn)


List of Figure

Figure 01: Global Prescription Pain Management Drugs Market Snapshot (2014)
Figure 02: Global Prescription Pain Management Drugs Market Value (US$ Bn) 2014–2021 
Figure 03: Global Opioids Market Value & Y-o-Y Growth (%) Forecast, 2015–2021
Figure 04: Global Opioids Market Absolute $ Opportunity, 2015–2021
Figure 05: Global Opioid Market Value Share & BPS Analysis, by Product Type, 2015 & 2021
Figure 06: Global Opioid Market Y-o-Y Growth Comparison, by Product Type, 2015–2021
Figure 07: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021
Figure 08: Global Opioid Market Absolute $ Opportunity, by Morphine, 2015–2021
Figure 09: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021
Figure 10: Global Opioid Market Absolute $ Opportunity, by Codeine, 2015–2021
Figure 11: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021
Figure 12: Global Opioid Market Absolute $ Opportunity, by Fentanyl, 2015–2021
Figure 13: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Meperidine, 2015–2021
Figure 14: Global Opioid Market Absolute $ Opportunity, by Meperidine, 2015–2021
Figure 15: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Methadone, 2015–2021
Figure 16: Global Opioid Market Absolute $ Opportunity, by Methadone, 2015–2021
Figure 17: Global Opioid Market Attractiveness Analysis, by Product Type, 2015–2021
Figure 18: Global Opioid Market Value Share & BPS Analysis, by application, 2015 & 2021
Figure 19: Global Opioid Market Y-o-Y Growth Comparison, by Application, 2015–2021
Figure 20: Global Opioid Product Type Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021
Figure 21: Global Opioid Market Absolute $ Opportunity, by Analgesia, 2015–2021
Figure 22: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021
Figure 23: Global Opioid Market Absolute $ Opportunity, by Cough Suppression, 2015–2021
Figure 24: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression, 2015–2021
Figure 25: Global Opioid Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021
Figure 26: Global Opioid Market Attractiveness Analysis, by Application, 2015–2021
Figure 27: Opioid Market Y-o-Y Growth Comparison, by Region, 2015–2021
Figure 28: Global Opioid Market Attractiveness Analysis, by Region, 2015–2021
Figure 29: Global Opioid Market Value Share & BPS Analysis, by Region, 2015 & 2021
Figure 30: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by North America, 2015–2021
Figure 31: Global Opioid Market Absolute $ Opportunity, by North America, 2015–2021
Figure 32: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Latin America, 2015–2021
Figure 33: Global Opioid Market Absolute $ Opportunity, by Latin America, 2015–2021
Figure 34: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Europe, 2015–2021
Figure 35: Global Opioid Market Absolute $ Opportunity, by Europe, 2015–2021
Figure 36: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Asia Pacific, 2015–2021
Figure 37: Global Opioid Market Absolute $ Opportunity, by Asia Pacific, 2015–2021
Figure 38: Global Opioid Market Value & Y-o-Y Growth (%) Forecast, by Middle East and Africa, 2015–2021
Figure 39: Global Opioid Market Absolute $ Opportunity, by Middle East and Africa, 2015–2021
Figure 40: North America Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021
Figure 41: U.S. Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 42: Canada Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 43: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021
Figure 44: North America Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021
Figure 45: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021
Figure 46: North America Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021
Figure 47: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021
Figure 48: North America Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021
Figure 49: North America Meperidine Opioids Market Value & Y-o-Y Growth (%), by Meperidine, 2015–2021
Figure 50: North America Meperidine Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021
Figure 51: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Methadone, 2015–2021
Figure 52: North America Opioids Market Absolute $ Opportunity, by Methadone, 2015–2021
Figure 53: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021
Figure 54: North America Opioids Market Absolute $ Opportunity, by Analgesia, 2015–2021
Figure 55: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021
Figure 56: North America Cough Suppression Opioids Market Absolute $ Opportunity, by Cough Suppression, 2015–2021
Figure 57: North America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression 2015–2021
Figure 58: North America Diarrhea Suppression Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021
Figure 59: North America Opioids Market Attractiveness Analysis, by Country, 2015–2021
Figure 60: North America Opioids Market Attractiveness Analysis, by Product Type, 2015–2021
Figure 61: North America Opioids Market Attractiveness Analysis, by Application, 2015–2021
Figure 62: Latin America Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021
Figure 63: Brazil Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 64: Argentina Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 65: Mexico Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 66: Rest of Latin America Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 67: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021
Figure 68: Latin America Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021
Figure 69: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021
Figure 70: Latin America Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021
Figure 71: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl 2015–2021
Figure 72: Latin America Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021
Figure 73: Latin America Opioids Market Value & Y-o-Y Growth (%), by Meperidine, 2015–2021
Figure 74: Latin America Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021
Figure 75: Latin America Methadone Opioids Market Value & Y-o-Y Growth (%), by Methadone, 2015–2021
Figure 76: Latin America Methadone Opioids Market Absolute $ Opportunity, by Methadone, 2015–2021
Figure 77: Latin America Opioid Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021
Figure 78: Latin America Opioid Analgesics Market Absolute $ Opportunity, by Analgesia, 2015–2021
Figure 79: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021
Figure 80: Latin America Opioids Market Absolute $ Opportunity, by Cough Suppression 2015–2021
Figure 81: Latin America Opioids Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression, 2015–2021
Figure 82: Latin America Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021
Figure 83: Latin America Opioids Market Attractiveness Analysis, by Country, 2015–2021
Figure 84: Latin America Opioids Market Attractiveness Analysis, by Product Type, 2015–2021
Figure 85: Latin America Opioids Market Attractiveness Analysis, by Application, 2015–2021
Figure 86: Europe Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021
Figure 87: Germany Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 88: U.K. Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 89: Italy Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 90: France Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 91: Spain Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 92: Russia Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 93: Rest of Europe Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 94: Europe Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine 2015–2021
Figure 95: Europe Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021
Figure 96: Europe Opioids Market Value & Y-o-Y Growth (%) forecast, by Codeine, 2015–2021
Figure 97: Europe Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021
Figure 98: Europe Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021
Figure 99: Europe Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021
Figure 100: Europe Opioids Market Value & Y-o-Y Growth (%) Forecast, by Meperidine, 2015–2021
Figure 101: Europe Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021
Figure 102: Europe Opioids Market Value & Y-o-Y Growth (%), forecast, by Methadone, 2015–2021
Figure 103: Europe Opioids Market Absolute $ Opportunity, by Methadone, 2015–2021
Figure 104: Europe Opioid Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021
Figure 105: Europe Opioid Market Absolute $ Opportunity, by Analgesia, 2015–2021
Figure 106: Europe Opioids Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021
Figure 107: Europe Opioids Market Absolute $ Opportunity, by Cough Suppression, 2015–2021
Figure 108: Europe Opioids Market Value & Y-o-Y Growth (%), Forecast, by Diarrhea Suppression, 2015–2021
Figure 109: Europe Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021
Figure 110: Europe Opioids Market Attractiveness Analysis, by Country, 2015–2021
Figure 111: Europe Opioids Market Attractiveness Analysis, by Product Type, 2015–2021
Figure 112: Europe Opioids Market Attractiveness Analysis, by Application, 2015–2021
Figure 113: Asia Pacific Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021
Figure 114: Greater China Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 115: India Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 116: ASEAN Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 117: ANZ Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 118: Rest of Asia Pacific Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 119: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021
Figure 120: Asia Pacific Morphine Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021
Figure 121: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021
Figure 122: Asia Pacific Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021
Figure 123: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021
Figure 124: Asia Pacific Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021
Figure 125: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Meperidine, 2015–2021
Figure 126: Asia Pacific Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021
Figure 127: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Methadone, 2015–2021
Figure 128: Asia Pacific Opioids Market Absolute $ Opportunity, by Methadone 2015–2021
Figure 129: Asia Pacific Opioid Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021
Figure 130: Asia Pacific Opioid Market Absolute $ Opportunity, by Analgesia, 2015–2021
Figure 131: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Cough Suppression, 2015–2021
Figure 132: Asia Pacific Opioids Market Absolute $ Opportunity, by Cough Suppression, 2015–2021
Figure 133: Asia Pacific Opioids Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression, 2015–2021
Figure 134: Asia Pacific Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021
Figure 135: Asia Pacific Opioids Market Attractiveness Analysis, by Country, 2015–2021
Figure 136: Asia Pacific Opioids Market Attractiveness Analysis, by Product Type, 2015–2021
Figure 137: Asia Pacific Opioids Market Attractiveness Analysis, by Application, 2015–2021
Figure 138: MEA Opioids Market Y-o-Y Growth Comparison, by Country, 2015–2021
Figure 139: GCC Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 140: South Africa Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 142: Rest of MEA Opioids Market: Absolute $ Opportunity, 2014–2021
Figure 143: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Morphine, 2015–2021
Figure 144: MEA Opioids Market Absolute $ Opportunity, by Morphine, 2015–2021
Figure 145: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Codeine, 2015–2021
Figure 146: MEA Opioids Market Absolute $ Opportunity, by Codeine, 2015–2021
Figure 147: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Fentanyl, 2015–2021
Figure 148: MEA Opioids Market Absolute $ Opportunity, by Fentanyl, 2015–2021
Figure 149: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Meperidine, 2015–2021
Figure 150: Opioids Market Absolute $ Opportunity, by Meperidine, 2015–2021
Figure 151: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Methadone, 2015–2021
Figure 152: MEA Opioids Market Absolute $ Opportunity, by Methadone, 2015–2021
Figure 153: MEA Opioid Market Value & Y-o-Y Growth (%) Forecast, by Analgesia, 2015–2021
Figure 154: MEA Opioid Market Absolute $ Opportunity, by Analgesia, 2015–2021
Figure 155: MEA Cough Suppression Opioids Market Value & Y-o-Y Growth (%), 2015–2021
Figure 156: MEA Cough Suppression Opioids Market Absolute $ Opportunity, 2015–2021
Figure 157: MEA Opioids Market Value & Y-o-Y Growth (%) Forecast, by Diarrhea Suppression, 2015–2021
Figure 158: MEA Opioids Market Absolute $ Opportunity, by Diarrhea Suppression, 2015–2021
Figure 159: MEA Opioids Market Attractiveness Analysis, by Country, 2015–2021
Figure 160: MEA Opioids Market Attractiveness Analysis, by Product Type, 2015–2021
Figure 161: MEA Opioids Market Attractiveness Analysis, by Application, 2015–2021

Back To Top